Pharmacy Times reports that, "The first PDMP program was enacted by New York State in 1918 and was used to monitor prescriptions for cocaine, codeine, heroin, morphine, and opium. With this program, pharmacists were required to report copies of prescriptions to the health department within 24 hours."
electronic decisions support,
Healthcare Databases,
controlled substances,
opioid legislation,
patient risk,
clinical practice improvement activities,
opioid prescribing,
prescriber compliance,
State Opioid Prescibing Guidelines,
Opioid Prescribing Guidelines,
Clinical Tools,
Pain Management,
chronic pain,
PDMPs,
Clinician Perspective,
Healthcare
PDMP's: A discussion For and Against a State By State Monitoring Program
opioid legislation,
regulations,
State Opioid Prescibing Guidelines,
chronic pain
State Spotlight: Oklahoma is OK for Medical Marijuana
Oklahoma recently became the 30th state in the US to allow access to medical marijuana. The proposal, which passed by a 57% to 43% margin allows doctors to recommend cannabis for any medical condition they deem medically necessary. This makes Oklahoma's law one of the least restrictive in the country.
weekend round up,
florida,
Connecticut,
controlled substances,
Healthcare,
Healthcare Databases,
opioid abuse,
opioid legislation,
Arizona,
patient safety,
Opioid Doses,
Opioid Epidemic,
tapering,
Medication Assisted Treatment Protocols,
prescription drug monitoring,
opioid prescribing compliance,
opioid prescribing,
regulations,
prescriber compliance,
State Opioid Prescibing Guidelines,
Chronic Pain Guidelines,
Opioid Prescribing Guidelines,
Guidelines,
compliance,
Smarter Pain Management,
Clinical Tools,
Opioid Therapy,
Integrated Pain,
chronic pain,
Opioid Misuse
Weekend Round Up: Healthcare Databases, Chronic Pain Patients Feel Caught in Debate and State Updates for Florida, and Connecticut
With opioid prescribing regulations being updated, national policy announcements, state guidelines as well as daily commentary regarding the opioid epidemic flooding news outlets, the AffirmHealth Weekend Round Up looks at the top headlines that caught our team’s eye. From controlled substance protocols to research focusing on pain management, addiction medicine, the ER and more provided to you in an easy to access summary. News you can use. Welcome to the Weekend Round Up.
Michigan,
opioid legislation,
patient safety,
Informed Consent,
Treatment Agreements,
risk assessment,
prescribing protocols,
Medication Assisted Treatment Protocols,
opioid prescribing compliance,
prescriber compliance,
Guidelines,
Clinical Tools,
Pain Management,
chronic pain,
PDMPs,
Opioid Epidemic
Michigan: Controlled Substance Legislation UPDATE
In December of 2017, Michigan’s Lt. Governor Brian Calley signed a comprehensive 10-bill package to address Michigan’s opioid epidemic, substance abuse and drug diversion problems. The multi-faceted package addresses various education initiatives from school aged children to patient informed consent and also covers acute pain prescriptions, MAPS and a variety of other topics impacting the prescribing of controlled substances in Michigan.
Kentucky,
Ketamine,
Opioid Misuse,
patient safety,
Opioid Epidemic,
weekend round up,
chronic pain,
Pain Management,
Opioid Therapy,
Guidelines
Weekend RoundUp: Ketamine Guidelines, Kentucky Sues Walgreens, SAMSHA Updates Opioid Toolkit and more
With opioid prescribing regulations being updated, national policy announcements, state guidelines as well as daily commentary regarding the opioid epidemic flooding news outlets, the AffirmHealth Weekend Round Up looks at the top headlines that caught our team’s eye. From controlled substance protocols to research focusing on pain management, addiction medicine, the ER and more provided to you in an easy to access summary. News you can use. Welcome to the Weekend Round Up.
opioid prescribing,
tapering,
chronic pain,
Pain Management
Opioid Tapering: Risks & Benefits from a Pain Management Leader
Determining when to taper
We hear a lot about opioid tapering from multiple different sources these days. It is mentioned in CDC guidelines and we get it from insurance companies as well. It seems that the insurance companies are trying to force you to taper all of your patients off of opioids, but as clinicians we know that some patients benefit from them and need them to maintain quality of life. So, how do we know who should be tapered? For me, the answer lies in the balance between risks and benefits. When the risks of any medication outweigh the benefits, then we should stop it. These risks can also be applied to the community if a patient is diverting their opioids.
After reviewing several articles regarding the controversy chronic pain patients are facing due to physicians changing policy in fear of the CDC Opioid Guidelines, I feel it necessary to address the seriousness of turning away legitimate chronic pain patients seeking medical care, because of the perceived stigma attached to opiates.
Clinician Perspective,
Finding a Pain Specialist,
Interventional Pain Management,
chronic pain,
Nashville,
Tennessee
Do I Need A Pain Specialist?
First, Let's Talk About My Pain.
Pain can be explained as either chronic or acute. Acute pain is described as pain that has just occurred after an injury such as surgery or trauma to our body. Acute pain will improve over time as our bodies heal from this injury or surgery.
Comments